Unilever

Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment offers skin cleansing, hair care, skin care, and deodorants categories. The Foods and Refreshment segment sells ice cream, savory, dressings, and tea. The Home Care segment includes fabric category and a wide range of cleaning products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever on January 1, 1930 and is headquartered in London, the United Kingdom.

Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever on January 1, 1930 and is headquartered in London, the United Kingdom.

GlaxoSmithKline

Shares in Unilever inched roughly 2% higher on Thursday after the consumer goods giant said it would not raise its rejected £50 billion ($68 billion) offer for GlaxoSmithKline's consumer health care business.

Unilever ends pursuit of GSK's consumer health business

Kimberly-Clark

Procter & Gamble

The reasons to consider this stock go well beyond its 4% dividend yield and deflated share price.

Should You Consider Buying This High-Yield Dividend Stock?

Glaxo says it will stick to its plan to separately list the consumer healthcare business in mid-2022.

Unilever Stock Rises After $68 Billion Bid for Glaxo's Consumer Arm Is Abandoned

Shares in Unilever PLC (LSE:ULVR) rose and GlaxoSmithKline PLC (LSE:GSK) fell after the Anglo-Dutch group said late yesterday it was abandoning its pursuit of the GSK Consumer Healthcare joint venture after criticism from investors. Consumer goods giant Unilever said as the markets closed it will not increase its offer above £50bn after the joint venture's owners GSK and Pfizer Inc (NYSE:PFE) argued the business was worth more.

Unilever drops bid for GSK Consumer Healthcare venture

Shares in consumer goods giant Unilever inched roughly 2% higher on Thursday after it said late on Wednesday it would not raise its rejected 50 billion pound ($68 billion) offer for GlaxoSmithKline's consumer healthcare business.

Unilever shares gain after opting not to lift bid for GSK assets

Unilever PLC (LSE:ULVR) has abandoned its pursuit of the Consumer Healthcare joint venture owned by GlaxoSmithKline PLC (LSE:GSK) and Pfizer Inc (NYSE:PFE) after criticism from investors. The Anglo-Dutch consumer goods giant said late yesterday that it will not increase its offer above £50bn after GSK and Pfizer said they felt the business was worth more.

Unilever drops bid for GSK Consumer Healthcare

A group of investors in Unilever said on Thursday they had filed a fresh resolution urging the company to fix a "crucial blind spot" in its strategy and set ambitious targets to sell healthier foods.

Unilever investors call AGM vote to push for healthy food targets

A day after a sharp drop, shares of the European consumer products and food maker rose. Only it wasn't a simple rebound -- Unilever did an about-face.

Why Unilever Stock Rose as Much as 10% Today

(Reuters) -Dove soap maker Unilever PLC said on Wednesday it would not increase its 50-billion-pound ($68 billion) proposal to buy GSK's consumer healthcare business.

Unilever will not increase 50-billion-pound offer for GSK consumer arm

The market hit more turbulence on Tuesday.

This Defensive Consumer Stock Fell More Than 2 Meme Stock Darlings Today

The Unilever bid for certain Glaxo assets produces a classic example of a standard arbitrage technique. Most takeovers and purchases lose money for the acquiring shareholders and make for the acquired.

Unilever And Glaxo - A Classic Arbitrage Example

Shares of the consumer goods giant dropped as investors digested a failed attempt to buy its way into the healthcare niche.

Why Unilever Stock Tanked 10% at the Open Today

Shares of Unilever plc (LON: ULVR) slid 4.0% on Monday after the British multinational said it was still interested in buying GlaxoSmithKline plc's (LON: GSK) consumer business. GSK continues to reject Unilever's proposals So far, GSK has rejected three of Unilever's proposals, including the most recent one that was valued at $68.25 billion.

Unilever is not giving up on GSK's consumer business

Executives at GlaxoSmithKline PLC ( GSK , Financial) confirmed on Saturday that they had received three unsolicited, conditional and non-binding proposals from Unilever PLC to acquire the GalxoSmithKline Consumer Healthcare business - and turned them all down because “they fundamentally undervalued the Consumer Healthcare business and its future prospects.”

GlaxoSmithKline Says 'No' 3 Times

Glaxo (GSK) rejects an offer from Unilever to acquire its consumer business worth 50 billion pounds ($68 billion). However, Unilever is likely to pursue the acquisition of the business.

Glaxo (GSK) Rejects Unilever's $68B Bid for Consumer Business

Unilever faces a dilemma after its 50 billion pound ($68 billion) offer for GlaxoSmithKline's consumer healthcare assets was rejected -- should it raise the bid and risk overpaying or seek another route to expand in healthcare?

Unilever's offer for GSK's consumer health raises doubts, questions over strategy

The British consumer goods giant has confirmed it has made an offer and is still interested in buying the consumer food healthcare division of GSK co-owned by Pfizer

Unilever's Bid for Glaxo's Consumer Assets - The Deal That No One Likes

Has there ever been a time in the last 50 years when investors and Unilever PLC (LSE:ULVR) management alike were not concerned about sluggish growth? With brands such as (deep breath) Hellmann's, Vaseline, Ben & Jerry's, Knorr, Magnum, Wall's, Cif, Domestos, Dove, Lifebuoy, Lux, Omo and Sunsilk, the company specialises in everyday products – and if you don't think Ben & Jerry's is an everyday product then you should meet my wife.

Unilever yet to demonstrate it would be the right owner of GSK's Consumer Healthcare division

Unilever shares slumped Monday as the consumer products giant suggested it might increase its offer for GlaxoSmithKline's consumer health unit.

London Markets: Unilever skids after attempt to snag Glaxo's consumer-health unit, as FTSE 100 climbs

GlaxoSmithKline PLC (LSE:GSK) said the £50bn offer by Unilever PLC (LSE:ULVR) for its Consumer Healthcare business fundamentally undervalues the business. Unilever made three unsolicited approaches to acquire the business – in which GlaxoSmithKline (GSK) has a 68% stake (the rest is owned by US drugs giant Pfizer Inc (NYSE:PFE)) – and all were rejected by GSK.

GlaxoSmithKline shares rise after it rejects Unilever bid for its consumer healthcare division

Unilever PLC (LSE:ULVR) has confirmed that it had a bid for GlaxoSmithKline's consumer healthcare business rebuffed. GlaxoSmithKline PLC (LSE:GSK) (GSK) revealed yesterday that it knocked back three approaches late last year from Unilever for its up for sale consumer healthcare business, with the last bid pitched at £41.7bn plus £8.3bn in shares.

Unilever intent on making big acquisitions in health, beauty and hygiene sectors despite knock-back in approach for GSK Consumer Healthcare

(Reuters) -Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business, calling it a "strong strategic fit" after its 50-billion-pound approach ($68.4 billion) was rejected.

Unilever says GSK consumer arm 'strong strategic fit' for business

GlaxoSmithKline and Pfizer will hold out for a better bid of at least £60 billion for their joint consumer healthcare venture, in opposition to an earlier offer they didn't like, Financial Times writes. They're rejecting a £50 billion offer from Unilever, which GSK said was “fundamentally undervalued.

GlaxoSmithKline, Unilever Spar Over Future of GSK's Consumer Health Business

Unilever Plc has held talks with banks about additional financing for a potential sweetened offer for GlaxoSmithKline Plc's consumer products division, Bloomberg reported on Sunday, citing people familiar with the matter.

Unilever to weigh raising offer for Glaxo Consumer unit - Bloomberg

GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business. The U.K. pharma giant says the business is well-positioned to sustainably grow ahead of its categories in the years to come.

News for Unilever Stock (UL)